trending Market Intelligence /marketintelligence/en/news-insights/trending/obq2okaq-v-ylm1qlpueda2 content esgSubNav
In This List

Webster Capital acquires JBR Clinical Research

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Webster Capital acquires JBR Clinical Research

Webster Capital said it acquired JBR Clinical Research, a Salt Lake City-based clinical research site manager that conducts studies on behalf of pharmaceutical companies.

The Waltham, Mass.-based private equity firm did not disclose financial details of the transaction.

"JBR helps reduce both the cost and time to bring a drug to market, creating value for sponsors and patients across the world," Mehran Ahmed, principal at Webster Capital, said in a news release.